{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:31:42Z","timestamp":1794486702525,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2024-I2M-C&T-B-075"],"award-info":[{"award-number":["2024-I2M-C&T-B-075"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["LC2024A18"],"award-info":[{"award-number":["LC2024A18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01787-7","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:06:14Z","timestamp":1776852374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical pathological characteristics and prognostic analysis of 140 cases of medullary thyroid carcinoma: validation of the international medullary thyroid carcinoma grading system in a chinese cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","unstructured":"Jung CK, Agarwal S, Hang JF, et al. Update on C-cell neuroendocrine neoplasm: prognostic and predictive histopathologic and molecular features of medullary thyroid carcinoma. Endocr Pathol. 2023;34(1):1\u201322. https:\/\/doi.org\/10.1007\/s12022-023-09753-5.","DOI":"10.1007\/s12022-023-09753-5"},{"issue":"4","key":"1787_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12022-012-9225-8","volume":"23","author":"BM Erovic","year":"2012","unstructured":"Erovic BM, Kim D, Cassol C, et al. Prognostic and predictive markers in medullary thyroid carcinoma. Endocr Pathol. 2012;23(4):232\u201342. https:\/\/doi.org\/10.1007\/s12022-012-9225-8.","journal-title":"Endocr Pathol"},{"issue":"12","key":"1787_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/hed.27181","volume":"44","author":"A Machens","year":"2022","unstructured":"Machens A, Lorenz K, Weber F, et al. Superiority of metastatic lymph node ratio over number of node metastases and TNM\/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer. Head Neck. 2022;44(12):2717\u201326. https:\/\/doi.org\/10.1002\/hed.27181.","journal-title":"Head Neck"},{"key":"1787_CR4","doi-asserted-by":"publisher","first-page":"153303382210784","DOI":"10.1177\/15330338221078435","volume":"21","author":"X Wu","year":"2022","unstructured":"Wu X, Li B, Zheng C. Clinical characteristics, surgical management, and prognostic factors of medullary thyroid carcinoma: a retrospective, single-center study. Technol Cancer Res Treat. 2022;21:15330338221078435. https:\/\/doi.org\/10.1177\/15330338221078435.","journal-title":"Technol Cancer Res Treat"},{"key":"1787_CR5","doi-asserted-by":"publisher","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3.","DOI":"10.1007\/s12022-022-09707-3"},{"issue":"5","key":"1787_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/cen.15195","volume":"102","author":"J Ni","year":"2025","unstructured":"Ni J, Zhang X, Liu Y, et al. A comparison of the predictive value of international medullary thyroid carcinoma grading system (IMTCGS) with that of other risk factors in a chinese medullary thyroid carcinoma cohort. Clin Endocrinol (Oxf). 2025;102(5):589\u201399. https:\/\/doi.org\/10.1111\/cen.15195.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"1787_CR7","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.modpat.2023.100235","volume":"36","author":"DJ Lubin","year":"2023","unstructured":"Lubin DJ, Behrman DB, Goyal S, et al. Independent validation of the international grading system for medullary thyroid carcinoma: a single institution experience. Mod Pathol. 2023;36(9):100235. https:\/\/doi.org\/10.1016\/j.modpat.2023.100235.","journal-title":"Mod Pathol"},{"issue":"3","key":"1787_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12022-022-09719-z","volume":"33","author":"E Vissio","year":"2022","unstructured":"Vissio E, Maletta F, Fissore J, et al. External validation of three available grading systems for medullary thyroid carcinoma in a single institution cohort. Endocr Pathol. 2022;33(3):359\u201370. https:\/\/doi.org\/10.1007\/s12022-022-09719-z.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1787_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12022-022-09718-0","volume":"33","author":"JF Williams","year":"2022","unstructured":"Williams JF, Zhao M, Najdawi F, et al. Grading of medullary thyroid carcinoma: an interobserver reproducibility study. Endocr Pathol. 2022;33(3):371\u20137. https:\/\/doi.org\/10.1007\/s12022-022-09718-0.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1787_CR10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00405-023-08341-x","volume":"281","author":"V Rai","year":"2024","unstructured":"Rai V, Saha A, Mehta S, et al. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience. Eur Arch Otorhinolaryngol. 2024;281(3):1571\u20139. https:\/\/doi.org\/10.1007\/s00405-023-08341-x.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1787_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.01329","volume":"40","author":"B Xu","year":"2022","unstructured":"Xu B, Fuchs TL, Ahmadi S, et al. International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma. J Clin Oncol. 2022;40(1):96\u2013104. https:\/\/doi.org\/10.1200\/JCO.21.01329.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1787_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/thy.2024.0444","volume":"35","author":"A Prete","year":"2025","unstructured":"Prete A, Torregrossa L, Gambale C, et al. The usefulness of the international grading system in the management of sporadic medullary thyroid carcinoma. Thyroid. 2025;35(4):387\u201396. https:\/\/doi.org\/10.1089\/thy.2024.0444.","journal-title":"Thyroid"},{"issue":"5","key":"1787_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers17050737","volume":"17","author":"EC Jager","year":"2025","unstructured":"Jager EC, van Hemel BM, Rutgers B, et al. Validation of the international medullary thyroid cancer grading system and identification of EZH2 as a prognostic and potential therapeutic marker in medullary thyroid cancer. Cancers (Basel). 2025;17(5):737. https:\/\/doi.org\/10.3390\/cancers17050737.","journal-title":"Cancers (Basel)"},{"key":"1787_CR14","doi-asserted-by":"publisher","unstructured":"Rossi ED, Raia S, Maratta M, et al. Immunohistochemical expression of Ki-67, INSM1, and SSTR2A in medullary thyroid carcinoma: correlation with tumor size, vascular invasion, and biochemical outcome. Virchows Arch Published online Oct. 2025;25. https:\/\/doi.org\/10.1007\/s00428-025-04287-z.","DOI":"10.1007\/s00428-025-04287-z"},{"issue":"2","key":"1787_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2023.0482","volume":"34","author":"S Censi","year":"2024","unstructured":"Censi S, Galuppini F, Clausi C, et al. Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma. Thyroid. 2024;34(2):177\u201385. https:\/\/doi.org\/10.1089\/thy.2023.0482.","journal-title":"Thyroid"},{"issue":"5","key":"1787_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/endrev\/bnad013","volume":"44","author":"ML Gild","year":"2023","unstructured":"Gild ML, Clifton-Bligh RJ, Wirth LJ, et al. Medullary thyroid cancer: updates and challenges. Endocr Rev. 2023;44(5):934\u201346. https:\/\/doi.org\/10.1210\/endrev\/bnad013.","journal-title":"Endocr Rev"},{"issue":"10","key":"1787_CR17","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.3390\/cancers12102894","volume":"12","author":"H Park","year":"2020","unstructured":"Park H, Park J, Choi MS, et al. Preoperative serum calcitonin and its correlation with extent of lymph node metastasis in medullary thyroid carcinoma. Cancers (Basel). 2020;12(10):2894. https:\/\/doi.org\/10.3390\/cancers12102894.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1787_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1530\/EJE-21-1015","volume":"186","author":"T Weber","year":"2022","unstructured":"Weber T, Poplawski A, Vorl\u00e4nder C, et al. Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients. Eur J Endocrinol. 2022;186(2):223\u201331. https:\/\/doi.org\/10.1530\/EJE-21-1015.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1787_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3760\/cma.j.cn112151-20250128-00067","volume":"54","author":"YL Yu","year":"2025","unstructured":"Yu YL, Liu ZY. New advances in pathological diagnosis of medullary thyroid carcinoma. Chin J Pathol. 2025;54(10):1016\u201321. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20250128-00067.","journal-title":"Chin J Pathol"},{"issue":"5","key":"1787_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41574-021-00470-9","volume":"17","author":"D Salvatore","year":"2021","unstructured":"Salvatore D, Santoro M, Schlumberger M. The importance of the RET gene in thyroid cancer and therapeutic implications. Nat Rev Endocrinol. 2021;17(5):296\u2013306. https:\/\/doi.org\/10.1038\/s41574-021-00470-9.","journal-title":"Nat Rev Endocrinol"},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.isci.2019.09.030","volume":"20","author":"R Ciampi","year":"2019","unstructured":"Ciampi R, Romei C, Ramone T, et al. Genetic landscape of somatic mutations in a large cohort of sporadic medullary thyroid carcinomas studied by next-generation targeted sequencing. iScience. 2019;20:324\u201336. https:\/\/doi.org\/10.1016\/j.isci.2019.09.030.","journal-title":"iScience"},{"issue":"4","key":"1787_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/biomedicines12040712","volume":"12","author":"T Chiba","year":"2024","unstructured":"Chiba T. Molecular pathology of thyroid tumors: essential points to comprehend regarding the latest WHO classification. Biomedicines. 2024;12(4):712. https:\/\/doi.org\/10.3390\/biomedicines12040712.","journal-title":"Biomedicines"},{"issue":"45","key":"1787_CR23","doi-asserted-by":"publisher","first-page":"e31705","DOI":"10.1097\/MD.0000000000031705","volume":"101","author":"C Xie","year":"2022","unstructured":"Xie C, Luo J, He Y, et al. BRCA2 gene mutation in cancer. Med (Baltim). 2022;101(45):e31705. https:\/\/doi.org\/10.1097\/MD.0000000000031705.","journal-title":"Med (Baltim)"},{"issue":"10","key":"1787_CR24","doi-asserted-by":"publisher","first-page":"e30655","DOI":"10.7759\/cureus.30655","volume":"14","author":"M Kuroki","year":"2022","unstructured":"Kuroki M, Shibata H, Iinuma R, et al. A case of thyroid carcinoma showing thymus-like differentiation with breast cancer susceptibility gene 2 mutation: a case report and literature review. Cureus. 2022;14(10):e30655. https:\/\/doi.org\/10.7759\/cureus.30655.","journal-title":"Cureus"},{"issue":"5","key":"1787_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/thy.2021.0571","volume":"32","author":"Z Wang","year":"2022","unstructured":"Wang Z, Tang C, Wang Y, et al. Inclusion of the number of metastatic lymph nodes in the staging system for medullary thyroid cancer: validating a modified american joint committee on cancer tumor-node-metastasis staging system. Thyroid. 2022;32(5):536\u201343. https:\/\/doi.org\/10.1089\/thy.2021.0571.","journal-title":"Thyroid"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01787-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:25:29Z","timestamp":1780626329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01787-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01787-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences (protocol number 25\/243\u20135189). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all individual participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}